ARS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 10.86 M | $136.63 M | 0.00% | 11.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 10.51 M | $132.27 M | 0.00% | 10.72% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 8.29 M | $104.27 M | 0.00% | 8.45% |
| BLACKROCK, INC. | 05/02/2025 | 4.30 M | $54.08 M | -6.02% | 4.38% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/13/2025 | 4.01 M | $50.48 M | 0.00% | 4.09% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 3.92 M | $49.35 M | 1.08% | 4.00% |
| VANGUARD GROUP INC | 05/09/2025 | 3.49 M | $43.88 M | 0.67% | 3.56% |
| STATE STREET CORP | 05/15/2025 | 2.03 M | $25.55 M | -26.13% | 2.07% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 1.86 M | $23.37 M | -6.01% | 1.89% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 1.60 M | $20.13 M | 220.00% | 1.63% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 1.31 M | $16.52 M | 100.00% | 1.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.26 M | $15.86 M | 1.80% | 1.29% |
| LEVIN CAPITAL STRATEGIES, L.P. | 05/09/2025 | 1.16 M | $14.65 M | 149.04% | 1.19% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 1.03 M | $12.95 M | 100.00% | 1.05% |
| ABRDN PLC | 05/13/2025 | 1.00 M | $12.61 M | 100.00% | 1.02% |
| FMR LLC | 05/12/2025 | 990.86 K | $12.47 M | -10.10% | 1.01% |
| 05/15/2025 | 936.73 K | $11.78 B | 100.00% | 0.96% | |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 807.04 K | $10.15 M | -14.08% | 0.82% |
| CITADEL ADVISORS LLC | 05/15/2025 | 801.29 K | $10.08 M | -0.52% | 0.82% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 717.95 K | $9.03 M | -18.98% | 0.73% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 706.79 K | $8.89 M | 13.40% | 0.72% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 669.01 K | $8.42 M | 12.76% | 0.68% |
| ROYCE & ASSOCIATES LP | 05/06/2025 | 642.77 K | $8.09 M | -30.86% | 0.66% |
| OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 625.00 K | $7.86 M | 100.00% | 0.64% |
| NICHOLAS INVESTMENT PARTNERS, LP | 05/15/2025 | 611.74 K | $7.70 M | 255.62% | 0.62% |
| WOODLINE PARTNERS LP | 05/15/2025 | 600.32 K | $7.55 M | -46.37% | 0.61% |
| UBS GROUP AG | 05/13/2025 | 591.18 K | $7.44 M | -41.62% | 0.60% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 04/25/2025 | 501.82 K | $6.31 M | 18.48% | 0.51% |
| NORTHERN TRUST CORP | 05/13/2025 | 487.04 K | $6.13 M | 1.86% | 0.50% |
| K2 PRINCIPAL FUND, L.P. | 05/15/2025 | 485.36 K | $6.11 M | 100.00% | 0.50% |
| JANNEY MONTGOMERY SCOTT LLC | 04/17/2025 | 448.67 K | $5.64 M | 1,552.07% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 444.70 K | $5.59 M | 176.29% | 0.45% |
| MORGAN STANLEY | 05/15/2025 | 442.51 K | $5.57 M | 2.29% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 416.66 K | $5.24 M | -2.53% | 0.42% |
| WEXFORD CAPITAL LP | 05/15/2025 | 408.55 K | $5.14 M | 10.57% | 0.42% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 04/24/2025 | 368.56 K | $4.64 M | 7.09% | 0.38% |
| ARDSLEY ADVISORY PARTNERS LP | 05/15/2025 | 325.00 K | $4.09 M | 100.00% | 0.33% |
| NEUBERGER BERMAN GROUP LLC | 05/13/2025 | 317.35 K | $3.99 M | 10.63% | 0.32% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 290.09 K | $3.65 M | -76.86% | 0.30% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 279.84 K | $3.52 M | 13.15% | 0.29% |
| ADVISOR RESOURCE COUNCIL | 04/22/2025 | 249.23 K | $3.14 M | 100.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 204.20 K | $2.57 M | 19.15% | 0.21% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 197.54 K | $2.49 M | 702.07% | 0.20% |
| LISANTI CAPITAL GROWTH, LLC | 04/25/2025 | 193.83 K | $2.44 M | 100.00% | 0.20% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 187.65 K | $2.36 M | -4.49% | 0.19% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 171.12 K | $2.15 M | -50.39% | 0.17% |
| MARSHALL WACE, LLP | 05/15/2025 | 156.64 K | $1.97 M | 196.06% | 0.16% |
| 05/12/2025 | 154.46 K | $1.94 M | 100.00% | 0.16% | |
| CITADEL ADVISORS LLC | 05/15/2025 | 142.60 K | $1.79 M | -38.13% | 0.15% |
| FAS WEALTH PARTNERS, INC. | 05/05/2025 | 139.54 K | $1.76 M | 47.34% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 199 institutional investors and hedge funds held shares of ARS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 10.51 M
ORBIMED ADVISORS LLC: 8.29 M
BlackRock, Inc.: 4.3 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
ALLIANCEBERNSTEIN L.P.: 3.92 M
77.73% of ARS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.83 M shares in the last 24 months. This purchase volume represents approximately $1.40 B in transactions.